SPL starpharma holdings limited

Access to antivirals in Australia - recent study

  1. 1,328 Posts.
    lightbulb Created with Sketch. 289
    https://theconversation.com/getting-antivirals-for-covid-too-often-depends-on-where-you-live-and-how-wealthy-you-are-239497?

    Censorship of medical professionals who are ONLY allowed to mention Paxlovid/lagevrio treatments as approved in ministerial statements and vaccines now a Pfizer mRNA monopoly. And TGA ban of Viraleze still on the infringement list and even though Astodrimer sodium as antiviral nasal spray has been scheduled, the Australian Register of Therapeutic Goods ARTG is still on approved registration go slow

    in the meantime look at the data in the article - Antiviral drugs Australian govt expenditure $1.7 billion - distribution bias to wealthy elderly and low socio economic and rural failure to include.

    Viraleze or Astodrimer sodium or SPL7013 whatever it is named is needed asap not just for healthy 12-70 yrs but those over 70 too. Plus govt needs to acknowledge failed placebo based studies of Lagevrio and poor data too on Paxlovid.

    And before someone says it - this is govt failure not Starpharma
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.4¢
Change
0.004(3.87%)
Mkt cap ! $39.31M
Open High Low Value Volume
9.0¢ 9.4¢ 9.0¢ $21.86K 237.3K

Buyers (Bids)

No. Vol. Price($)
2 120141 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 13999 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.